Executive Vice President and Chief Commercial Officer
Mr. Buck is an experienced healthcare leader with over 25 years of operational experience in various functional roles such as global business and product development, licensing and acquisitions, venture investment and commercial sales management.
At HeartFlow, he is responsible for expanding and accelerating global market adoption of the company’s HeartFlow® FFRCT Analysis. Prior to HeartFlow, Mr. Buck was president of the medical products division for Cardinal Health, with global responsibility for the Cardinal brand product portfolio. Prior to Cardinal Health, he held several senior leadership roles at Abbott Laboratories, including vice president of global market development, vice president of licensing and acquisitions, and vice president of venture investing. Previously, he held commercial leadership positions at Novoste Corporation, Boston Scientific and Smith & Nephew.
Mr. Buck earned a B.A. degree in economics from the University of Iowa and currently serves on the board of directors of Cibiem, Inc.